Neutrophil-to-lymphocyte ratio trend: A novel prognostic predictor in patients with nasopharyngeal carcinoma receiving radiotherapy.

IF 2.3 4区 医学 Q3 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Pei Yang, Yu Zhao, Hao Liang, Guanzhi Zhou, Bassem Youssef, Hesham Elhalawani, Meizhen Li, Fengbo Tan, Yi Jin, Hekun Jin, Hong Zhu, Abdallah Sherif Radwan Mohamed, Nantavithya Chonnipa, Danita Kannarunimit, Yingrui Shi, Hui Wang, Clifton David Fuller
{"title":"Neutrophil-to-lymphocyte ratio trend: A novel prognostic predictor in patients with nasopharyngeal carcinoma receiving radiotherapy.","authors":"Pei Yang,&nbsp;Yu Zhao,&nbsp;Hao Liang,&nbsp;Guanzhi Zhou,&nbsp;Bassem Youssef,&nbsp;Hesham Elhalawani,&nbsp;Meizhen Li,&nbsp;Fengbo Tan,&nbsp;Yi Jin,&nbsp;Hekun Jin,&nbsp;Hong Zhu,&nbsp;Abdallah Sherif Radwan Mohamed,&nbsp;Nantavithya Chonnipa,&nbsp;Danita Kannarunimit,&nbsp;Yingrui Shi,&nbsp;Hui Wang,&nbsp;Clifton David Fuller","doi":"10.1177/03936155221110250","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Peripheral neutrophil-lymphocyte ratio (NLR), reflecting immune-inflammation status, shows great potential for tumor progression and outcome. Pre-treatment NLR does not fully reflect the immune-inflammatory response to treatment. This study aimed to introduce the NLR trend as a new indicator and to investigate its prognostic value in patients with nasopharyngeal carcinoma receiving radiotherapy.</p><p><strong>Methods: </strong>This retrospective study evaluated patients with nasopharyngeal carcinoma treated with radiotherapy. The NLR trend value was calculated from the fitted line gradient via the NLRs before, during (at least once), and after each patient's first radiotherapy. The Kaplan-Meier curve and log-rank test were used to calculate and compare survival outcomes of different pretreatment NLRs and NLR trends for progression-free survival, locoregional recurrence-free survival (LRFS), and overall survival at 3 and 5 years. Multivariate Cox regression analyses were performed to assess the association between the NLR trend plus 3- and 5-year overall survival.</p><p><strong>Results: </strong>The study included 528 patients. A lower NLR trend predicted worse progression-free survival, LRFS, plus 3- and 5-year overall survival. Multivariate Cox regression analysis showed that the NLR trend independently predicted 3- and 5-year overall survival. Sub-group analysis showed that the prognosis of patients with a low pretreatment NLR and a high NLR trend were superior to those of other groups.</p><p><strong>Conclusion: </strong>The NLR trend independently predicted the prognosis of patients with nasopharyngeal carcinoma receiving radiotherapy. The NLR trend and the pretreatment NLR combination is more precise than pretreatment NLR in predicting prognosis. A high NLR trend may be evidence of a positive immune response to radiotherapy in patients with nasopharyngeal carcinoma.</p>","PeriodicalId":50334,"journal":{"name":"International Journal of Biological Markers","volume":null,"pages":null},"PeriodicalIF":2.3000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Biological Markers","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/03936155221110250","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/6/30 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 2

Abstract

Background: Peripheral neutrophil-lymphocyte ratio (NLR), reflecting immune-inflammation status, shows great potential for tumor progression and outcome. Pre-treatment NLR does not fully reflect the immune-inflammatory response to treatment. This study aimed to introduce the NLR trend as a new indicator and to investigate its prognostic value in patients with nasopharyngeal carcinoma receiving radiotherapy.

Methods: This retrospective study evaluated patients with nasopharyngeal carcinoma treated with radiotherapy. The NLR trend value was calculated from the fitted line gradient via the NLRs before, during (at least once), and after each patient's first radiotherapy. The Kaplan-Meier curve and log-rank test were used to calculate and compare survival outcomes of different pretreatment NLRs and NLR trends for progression-free survival, locoregional recurrence-free survival (LRFS), and overall survival at 3 and 5 years. Multivariate Cox regression analyses were performed to assess the association between the NLR trend plus 3- and 5-year overall survival.

Results: The study included 528 patients. A lower NLR trend predicted worse progression-free survival, LRFS, plus 3- and 5-year overall survival. Multivariate Cox regression analysis showed that the NLR trend independently predicted 3- and 5-year overall survival. Sub-group analysis showed that the prognosis of patients with a low pretreatment NLR and a high NLR trend were superior to those of other groups.

Conclusion: The NLR trend independently predicted the prognosis of patients with nasopharyngeal carcinoma receiving radiotherapy. The NLR trend and the pretreatment NLR combination is more precise than pretreatment NLR in predicting prognosis. A high NLR trend may be evidence of a positive immune response to radiotherapy in patients with nasopharyngeal carcinoma.

中性粒细胞与淋巴细胞比值趋势:鼻咽癌放疗患者的一种新的预后预测因子。
外周中性粒细胞-淋巴细胞比率(NLR)反映了免疫炎症状态,显示了肿瘤进展和结局的巨大潜力。治疗前NLR不能完全反映对治疗的免疫炎症反应。本研究旨在引入NLR趋势作为一个新的指标,探讨其在鼻咽癌放疗患者中的预后价值。方法:回顾性研究鼻咽癌放疗患者。通过每位患者第一次放疗前、期间(至少一次)和之后的NLR,从拟合的线梯度计算NLR趋势值。采用Kaplan-Meier曲线和log-rank检验计算和比较不同预处理NLR的生存结果和NLR趋势的无进展生存、局部无复发生存(LRFS)和3年和5年总生存。进行多变量Cox回归分析,评估NLR趋势与3年和5年总生存率之间的关系。结果:纳入528例患者。较低的NLR趋势预示着较差的无进展生存期(LRFS)以及3年和5年总生存期。多因素Cox回归分析显示NLR趋势独立预测3年和5年总生存。亚组分析显示,预处理NLR低、NLR趋势高的患者预后优于其他组。结论:NLR趋势独立预测鼻咽癌放疗患者的预后。NLR趋势和预处理NLR联合预测预后比预处理NLR更准确。高NLR趋势可能是鼻咽癌患者放射治疗免疫反应阳性的证据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
International Journal of Biological Markers
International Journal of Biological Markers 医学-生物工程与应用微生物
CiteScore
4.10
自引率
0.00%
发文量
43
期刊介绍: IJBM is an international, online only, peer-reviewed Journal, which publishes original research and critical reviews primarily focused on cancer biomarkers. IJBM targets advanced topics regarding the application of biomarkers in oncology and is dedicated to solid tumors in adult subjects. The clinical scenarios of interests are screening and early diagnosis of cancer, prognostic assessment, prediction of the response to and monitoring of treatment.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信